OR WAIT null SECS
Jill Murphy is Editor of Pharmaceutical Technology.
August 10, 2023
The site was acquired by AGC Biologics in July 2020, and the Milan location is the first cell and gene therapy site approved in Europe for GMP manufacturing of clinical and commercial supplies.
The initial collaboration between the two companies began in 2017 with an extension announced in 2021.
August 09, 2023
SBS-518 is a first-in-class dual sigma receptor (SR) antagonist/dopamine transporter (DAT) inhibitor in development for the treatment of stimulant use disorder (StUD).
August 08, 2023
The bioreactors can integrate with Emerson’s DeltaV PK Controller in addition to S-Series and M-Series controllers.
August 07, 2023
BlueRock will be responsible for the global development and commercialization of therapeutic candidates emerging from this collaboration.
August 03, 2023
Laboratories are focusing on more automated processes while also trying to maintain an efficient, safe, and personalized experience with each analytical test.